House Bill 346

Last Action 02/16/23: to Committee on Committees (H)
Title AN ACT relating to biosimilar medicines.
Bill Documents Introduced
Bill Request Number 1287
Sponsor K. Moser
Summary of Original Version Amend KRS 304.17A-163 to permit insurers to require insureds to try biosimilar biological products prior to providing coverage for the equivalent branded prescription drug under certain circumstances; amend KRS 217.814 to define biosimilar biological product; amend KRS 217.822 to require dispensing of biosimilar biological products under certain circumstances.
Index Headings of Original Version Drugs and Medicines - Biosimilar medicines, provision
Health and Medical Services - Biosimilar medicines, provision
Insurance, Health - Biosimilar medicines, coverage requirement
Pharmacists - Biosimilar medicines, provision


  • introduced in House
  • to Committee on Committees (H)

Last updated: 11/9/2023 3:03 PM (EST)